Humulin R
Metabolic Disease
University of CopenhagenN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
9 Active assets in the Metabolic Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tirzepatide Washington University School of Medicine | Phase 4 | BBB |
MIDAZOLAM Baskent University | Phase 4 | BB |
GLUCOSE, ANHYDROUS University Hospital Schleswig-Holstein | Phase 4 | BB |
Terazosin I.R.C.C.S. Fondazione Santa Lucia | Phase 4 | BB |
PROPOFOL Baskent University | Phase 4 | BB |
View all 32 →
Same molecule, other indications
Humulin R is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →